All United Kingdom articles

  • AdobeStock_603386437_Editorial_Use_Only
    Industry news

    Patients warned about falsified Ozempic medication


    The EMA has warned patients and healthcare professionals across the EU about pre-filled injection pens falsely labelled as Ozempic.

  • AdobeStock_99786199
    Industry news

    UK and Ireland VetMed product label guidance


    Ireland’s HPRA and the UK’s VMD have produced interim guidance clarifying the joint labels for veterinary medicines authorised in the two countries.

  • Brexit supply chain

    Brexit − Regulatory and supply chain considerations


    The UK formally left the EU on 31 January 2020 and the transition period, as set out in the withdrawal agreement, came to an end on 31 December 2020. During this transition period, the UK continued to remain under EU pharmaceutical law. From 1 January 2021, the UK adopted an ...

  • post brexit

    Pharmacovigilance regulations post-Brexit


    The UK (Great Britain and Northern Ireland) has left the EU and the Brexit transition period has passed. This article covers points to consider when ensuring that pharmacovigilance systems for human medicinal products are compliant with EU and UK requirements. The UK requirements largely mirror the existing EU pharmacovigilance (PV) ...